155 related articles for article (PubMed ID: 34168448)
1. Erratum: A High Bioavailability and Sustained-Release Nano-Delivery System for Nintedanib Based on Electrospray Technology [Corrigendum].
Int J Nanomedicine; 2021; 16():4179-4181. PubMed ID: 34168448
[TBL] [Abstract][Full Text] [Related]
2. Erratum: Change of Nano Material Electrical Characteristics for Medical System Applications [Corrigendum].
Int J Nanomedicine; 2022; 17():3671-3672. PubMed ID: 36051352
[TBL] [Abstract][Full Text] [Related]
3. Erratum: Antitumor Effect of a New Nano-Vector with miRNA-135a on Malignant Glioma [Corrigendum].
Int J Nanomedicine; 2020; 15():5179. PubMed ID: 32801684
[TBL] [Abstract][Full Text] [Related]
4. Erratum: Implementation of PPI with Nano Amorphous Oxide Semiconductor Devices for Medical Applications [Corrigendum].
Int J Nanomedicine; 2020; 15():9497-9498. PubMed ID: 33281444
[TBL] [Abstract][Full Text] [Related]
5. Erratum: Synthesis, Construction, and Evaluation of Self-Assembled Nano-Bacitracin a as an Efficient Antibacterial Agent in vitro and in vivo [Corrigendum].
Int J Nanomedicine; 2020; 15():4753. PubMed ID: 32753863
[TBL] [Abstract][Full Text] [Related]
6. Erratum: Precisely Fabricated Sulpiride-Loaded Nanolipospheres with Ameliorated Oral Bioavailability and Antidepressant Activity [Corrigendum].
Int J Nanomedicine; 2023; 18():2069-2070. PubMed ID: 37101839
[TBL] [Abstract][Full Text] [Related]
7. Erratum: Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Corrigendum].
Int J Nanomedicine; 2020; 15():6561-6562. PubMed ID: 32982217
[TBL] [Abstract][Full Text] [Related]
8. Erratum: Insights into the Antibacterial Mechanism of PEGylated Nano-Bacitracin A Against Streptococcus pneumonia: Both Penicillin-Sensitive and Penicillin-Resistant Strains [Corrigendum].
Int J Nanomedicine; 2022; 17():2807-2808. PubMed ID: 35791308
[TBL] [Abstract][Full Text] [Related]
9. Erratum: Combined Molybdenum Gelatine Methacrylate Injectable Nano-Hydrogel Effective Against Diabetic Bone Regeneration [Corrigendum].
Int J Nanomedicine; 2023; 18():7205-7208. PubMed ID: 38076732
[TBL] [Abstract][Full Text] [Related]
10. Erratum: miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum].
Int J Nanomedicine; 2020; 15():8293-8294. PubMed ID: 33149576
[TBL] [Abstract][Full Text] [Related]
11. Erratum: Tuning the Surface Coating of IONs Toward Efficient Sonochemical Tethering and Sustained Liberation of Topoisomerase II Poisons [Corrigendum].
Int J Nanomedicine; 2021; 16():1707-1708. PubMed ID: 33688186
[TBL] [Abstract][Full Text] [Related]
12. Erratum: Construction and in vivo/in vitro Evaluation of a Nanoporous Ion-Responsive Targeted Drug Delivery System for Recombinant Human Interferon α-2b Delivery [Corrigendum].
Int J Nanomedicine; 2021; 16():4191-4192. PubMed ID: 34168451
[TBL] [Abstract][Full Text] [Related]
13. Erratum: Carbon Nanotubes: Smart Drug/Gene Delivery Carriers [Corrigendum].
Int J Nanomedicine; 2021; 16():7283-7284. PubMed ID: 34737565
[TBL] [Abstract][Full Text] [Related]
14. Erratum: Self-Assembled Nano-Peptide Hydrogels with Human Umbilical Cord Mesenchymal Stem Cell Spheroids Accelerate Diabetic Skin Wound Healing by Inhibiting Inflammation and Promoting Angiogenesis [Corrigendum].
Int J Nanomedicine; 2022; 17():3057-3058. PubMed ID: 35844972
[TBL] [Abstract][Full Text] [Related]
15. Erratum: Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum].
Int J Nanomedicine; 2019; 14():7919. PubMed ID: 31632008
[TBL] [Abstract][Full Text] [Related]
16. Erratum: Anti-Inflammatory Effects of Magnetically Targeted Mesenchymal Stem Cells on Laser-Induced Skin Injuries in Rats [Corrigendum].
Int J Nanomedicine; 2020; 15():6735-6736. PubMed ID: 33061356
[TBL] [Abstract][Full Text] [Related]
17. Erratum: Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature [Corrigendum].
Int J Nanomedicine; 2022; 17():183-184. PubMed ID: 35046653
[TBL] [Abstract][Full Text] [Related]
18. Erratum: Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum].
Int J Nanomedicine; 2021; 16():5099. PubMed ID: 34349509
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Enhanced Antitumor Efficacy of Macrophage-Mediated Egg Yolk Lipid-Derived Delivery System Against Breast Cancer [Corrigendum].
Int J Nanomedicine; 2021; 16():237-238. PubMed ID: 33469283
[TBL] [Abstract][Full Text] [Related]
20. Erratum: Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum].
Int J Nanomedicine; 2020; 15():8873-8874. PubMed ID: 33204093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
